2011 President, Medicine & Science
American Diabetes Association (ADA)
Chief, Center for Metabolic Research
Chief, Section of Endocrinology, Metabolism & Diabetes
Veterans Affairs Healthcare System, San Diego, CA
Robert R. Henry‚ M.D. is the 2011 President‚ Medicine & Science of the American Diabetes Association‚ the nation’s largest voluntary health organization leading the fight to Stop Diabetes®.
He is also Professor of Medicine‚ Department of Medicine‚ Division of Endocrinology and Metabolism at the University of California‚ San Diego‚ and Chief of the Section on Diabetes‚ Endocrinology‚ and Metabolism and Director of the Center for Metabolic Research at the VA San Diego Healthcare System.
Dr. Henry received his medical degree from the University of Manitoba Medical School, Manitoba, Canada, where he also completed his residency in internal medicine and fellowship in endocrinology.
He has been Visiting Assistant Professor of Medicine, Diabetic Research Unit, at the University of Colorado Health Sciences Center, Visiting Assistant Research Endocrinologist at the University of California, San Diego, and Visiting Professor of Medicine at the University of Edinburgh, Royal Infirmary.
He is a member of several professional societies, including the American Diabetes Association, the European Association for the Study of Diabetes, the North American Association for the Study of Obesity, the Endocrine Society, the Royal College of Physicians and Surgeons of Canada and Edinburgh, and the American Federation for Clinical Research.
His research is funded by the National Institutes of Health-NIDDK, the American Diabetes Association, the Department of Veterans Affairs and numerous pharmaceutical grants. Recent awards include the Distinguished Clinical Scientist Award from the American Diabetes Association, the Mary Jane Kugal Award of the Juvenile Diabetes Research Foundation International, the Pfizer Visiting Professorship in Diabetes and the Robert H. Williams-Rachmiel Levine Award from the Western Metabolism Club.
Dr. Henry has published more than 250 journal articles and chapters. His current research interests involve the therapeutic mechanisms of novel therapies for diabetes and obesity as well as the metabolic and cardiovascular effects of human adipose tissue secretory products including adiponectin and other adipokines.
These studies are focused primarily on signal interactions between skeletal muscle and adipose tissue and defects of insulin secretion and signal transduction in these tissues of obese and type 2 diabetic patients.